跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
駱 俊良
教授
生物醫學工程學系
https://orcid.org/0000-0002-5026-3584
電話
02-2826-7914(office) , 02-2826-7000#65569, 65517, 65531(lab)
電子郵件
cllo
nycu.edu
tw
網站
https://menadionekimo.wixsite.com/mysite-1
h-index
h10-index
h5-index
2159
引文
27
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
650
引文
17
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
305
引文
9
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1999 …
2025
每年研究成果
概覽
指紋
網路
研究成果
(52)
類似的個人檔案
(5)
指紋
查看啟用 Chun-Liang Lo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Micelle
99%
Copolymer
85%
Doxorubicin
73%
Neoplasm
70%
Nanoparticle
51%
Polyethylene Glycol
30%
Chemotherapy
28%
Liposome
27%
Cytotoxicity
25%
Reactive Oxygen Metabolite
22%
Colon Carcinoma
20%
Drug Release
19%
Anticarcinogen
17%
Immunotherapy
17%
Breast Cancer
16%
Combination Therapy
16%
Small Interfering RNA
16%
Macrogol
16%
Micellar System
14%
Tumor Microenvironment
12%
Macrogol Derivative
12%
Alpha Tocopherol
12%
Intracellular Drug Delivery
12%
Hypoxia
11%
Imiquimod
10%
Methacrylate
10%
Histidine
10%
Triple Negative Breast Cancer
7%
Pyridoxal
7%
Anticancer Drug
7%
Focal Adhesion Kinase
6%
Janus Kinase 1
6%
Nanomaterial
6%
Acrylamide
6%
Folic Acid
6%
Photothermal Therapy
6%
Transcytosis
6%
Ceramide
6%
Hydrogen Bond
6%
Glucosamine
6%
Camptothecin
6%
Hyaluronic Acid
6%
Cancer Chemotherapy
5%
Side Effect
5%
Poly(methacrylic Acid)
5%
2 Methacryloyloxyethylphosphorylcholine
5%
Chitosan
5%
Rapamycin
5%
Mercaptopurine
5%
Keyphrases
Diblock Copolymer
53%
Doxorubicin
50%
Cancer Cells
39%
Mixed Micelles
32%
Graft Copolymer
32%
Tumor
29%
Cancer Therapy
27%
Nanoparticles
27%
Copolymer
27%
In Cancer
24%
Doxorubicin-loaded
24%
Reactive Oxygen Species Responsive
21%
Anticancer Drugs
21%
Poly(D,L-lactide)
18%
Drug Delivery
18%
Methoxy Poly(ethylene glycol)
18%
PH-sensitive
18%
PEG-PLA
17%
Cancer Stem Cells
16%
Vitamin E
16%
Polymer Nanoparticles
16%
Small Interfering RNA (siRNA)
16%
Tumor Accumulation
16%
Cellular Uptake
16%
Polymeric Nanoparticles
15%
Cancer Treatment
15%
Liposomes
14%
Chemotherapy
14%
Liposomal
13%
Histidine
13%
Intracellular Drug Delivery
13%
Poly(N-isopropylacrylamide) (PNIPAM)
12%
Nanotherapeutics
12%
Multifunctional Micelles
12%
Lipids
12%
Colon Surgery
11%
Therapeutic Efficacy
11%
Imiquimod
11%
Anticancer Therapy
11%
Reactive Oxygen Species
11%
Cytotoxicity
11%
Endosome
11%
Nanomaterials
10%
Multifunctional Polymer
10%
Lipophilic Complex
10%
Cancer Cell Targeting
10%
Lactide
10%
Co-delivery
10%
Doxorubicin Delivery
10%
Silicone 3D Printing
10%